Oxygen homeostasis

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 2, Issue 3, 2010, Pages 336-361

  Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAZOA;

HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN;

ANIMAL; BIOLOGICAL MODEL; HOMEOSTASIS; HUMAN; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MODELS, BIOLOGICAL; OXYGEN; OXYGEN CONSUMPTION; SIGNAL TRANSDUCTION;

EID: 77954345078     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.69     Document Type: Review

References (278)

1. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454.
2. 2 tension. Proc Natl Acad Sci U S A 1995, 92:5510-5514.
3. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995, 270:1230-1237.
4. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1(regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 1997, 94:4273-4278.
5. Flamme I, Fröhlich T, von Reutern M, Kappel A, Damert A, et al. HRF, a putative basic helixloop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels. Mech Dev 1997, 63:51-60.
6. Hogenesch JB, Chan WK, Jackiw VH, Brown RC, Gu YZ, et al. Characterization of a subset of the basichelix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J Biol Chem 1997, 272:8581-8593.
7. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997, 11:72-82.
8. WiesenerMS, TurleyH, AllenWE,Willam C, Eckardt KU, et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood 1998, 92:2260-2268.
9. Patel SA, Simon MC. Biology of hypoxia-inducible factor-2α in development and disease. Cell Death Differ 2008, 15:628-634.
10. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996, 271:17771-17778.
11. Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 1992, 256:1193-1195.
12. Gu YZ, Hogenesch JB, Bradfield CA. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000, 40:519-561.
13. Yu AY, Frid MG, Shimoda LA,Wiener CM, Stenmark K, et al. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 1998, 275:L818-L826.
14. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999, 11:4159-4170.
15. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008, 453:807-811.
16. van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem J 2008, 412:477-484.
17. Thomas JD, Johannes GJ. Identification of mRNAs that continue to associate with polysomes during hypoxia. RNA 2007, 13:1116-1131.
18. van den Beucken T, Koritzinsky M, Wouters BG. Translational control of gene expression during hypoxia. Cancer Biol Ther 2006, 5:749-755.
19. Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1(mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell 2002, 13:1792-1801.
20. Schepens B, Tinton SA, Bruynooghe Y, Beyaert R, Cornelis S. The polypyrimidine tract-binding protein stimulates HIF-1α IRES-mediated translation during hypoxia. Nucleic Acids Res 2005, 33:6884-6894.
21. Galbán S, Kuwano Y, Pullmann R Jr, Martindale JL, Kim HH, Lal A, et al. RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1α. Mol Cell Biol 2008, 28:93-107.
22. Young RM,Wang SJ, Gordan JD, Ji X, Liebhaber SA, SimonMC. Hypoxia-mediated selectivemRNA translation by an internal ribosome entry site-independent mechanism. J Biol Chem 2008, 283:16309-16319.
23. Laughner E, Taghavi P, Chiles K,Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α ) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001, 21:3995-4004.
24. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/ phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000, 60:1541-1545.
25. Arsham AM, Howell JJ, SimonMC. A novel hypoxiainducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem2003, 278:29655-29660.
26. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004, 18:2893-2904.
27. Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, et al. Identification of hypoxia-inducible factor 1(as a novel target for miR-17-92 microRNA cluster. Cancer Res 2008, 68:5540-5545.
28. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, et al. HIF-2(, but not HIF-1α , promotes iron absorption in mice. J Clin Invest 2009, 119:1159-1166.
29. Sanchez M, Galy B, Muckenthaler MU, Hentze MW. Iron-regulatory proteins limit hypoxia-inducible factor-2(expression in iron deficiency.Nat StructMol Biol 2007, 14:420-426.
30. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, et al. Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J 2001, 15:1312-1314.
31. 2 tension. Am J Physiol 1996, 271:C1172-C1180.
32. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008, 30:393-402.
33. Chowdhury R, Hardy A, Schofield CJ. The human oxygen sensing machinery and its manipulation. Chem Soc Rev 2008, 37:1308-1319.
34. Berra E, Benizri E, Ginouvès A, Volmat V, Roux D, et al. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 2003, 22:4082-4090.
35. Baek JH, Mahon PC, Oh J, Kelly B, Krishnamachary B, et al. OS-9 interacts with hypoxia-inducible factor 1(and prolyl hydroxylases to promote oxygendependent degradation of HIF-1α . Mol Cell 2005, 17:503-512.
36. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, et al. Concordant regulation of gene expression by hypoxia and 2-oxoglutaratedependent dioxygenase inhibition: the role of HIF-1α , HIF-2(, and other pathways. J Biol Chem 2006, 281:15215-15226.
37. Kaelin WG. Von Hippel-Lindau disease. Annu Rev Pathol 2007, 2:145-173.
38. Baek JH, Liu YV, McDonald KR, Wesley JB, Hubbi ME, et al. Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1α. J Biol Chem2007, 282:23572-23580.
39. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, et al. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275.
40. Li Z, Wang D, Messing EM, Wu G. VHL proteininteracting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α . EMBO Rep 2005, 6:373-378.
41. Li Z, Wang D, Messing EM, Wu G. Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. Biochem Biophys Res Commun 2002, 294:700-709.
42. Rane S, He M, Sayed D, Vashistha H, Malhotra A, et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1αand Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009, 104:879-886.
43. Gradin K, McGuire J, Wenger RH, Kvietikova I, Whitelaw ML, et al. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor.Mol Cell Biol 1996, 16:5221-5231.
44. Minet E,Mottet D,Michel G, Roland I, RaesM, et al. Hypoxia-induced activation of HIF-1: role of HIF-1α -Hsp90 interaction. FEBS Lett 1999, 460:251-256.
45. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, et al. Hsp90 regulates a von Hippel Lindauindependent hypoxia-inducible factor-1α-degradative pathway. J Biol Chem 2002, 277:29936-29944.
46. 2-independent and HSP90 inhibitor-induced degradation of HIF-1α . Mol Cell 2007, 25:207-217.
47. 1-acetyltransferase-1 binds to hypoxia-inducible factor-1α(HIF-1α ) and RACK1 and promotes ubiquitination and degradation of HIF-1α . J Biol Chem 2007, 282:33358-33366.
48. Liu YV, Hubbi ME, Pan F, McDonald KR, Mansharamani M, et al. Calcineurin promotes hypoxiainducible factor 1αexpression by dephosphorylating RACK1 and blocking RACK1 dimerization. J Biol Chem 2007, 282:37064-37073.
49. Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF-1α during hypoxia. Cell 2007, 131:584-595.
50. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia. Cell 2007, 131:309-323.
51. Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL. Transactivation and inhibitory domains of hypoxiainducible factor 1α. Modulation of transcriptional activity by oxygen tension. J Biol Chem 1997, 272:19253-19260.
52. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit. J Biol Chem 1997, 272:11205-11214.
53. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001, 15:2675-2686.
54. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002, 16:1466-1471.
55. Peng ZG, Zhou MY, Huang Y, Qiu JH, Wang LS, et al. Physical and functional interaction of Runtrelated protein 1 with hypoxia-inducible factor-1α Oncogene 2008, 27:839-847.
56. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, et al. Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 2002, 111:709-720.
57. Hogenesch JB, Gu YZ, Jain S, Bradfield CA. The basic-helix-loop-helix-PAS orphanMOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci U S A 1998, 95:5474-5479.
58. Takahata S, SogawaK,Kobayashi A, EmaM,Mimura J, et al. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1α , HLF, and clock. Biochem Biophys Res Commun 1998, 248:789-794.
59. LaRusch GA, Jackson MW, Dunbar JD, Warren RS, Donner DB, et al. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1α and Hdm2. J Biol Chem 2006, 281:16814-16820.
60. Kaidi A, Williams AC, Paraskeva C. Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007, 9:210-217.
61. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, et al. Molecular mechanisms of transcription activation by HLF and HIF-1α in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J 1999, 18:1905-1914.
62. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, et al. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α. Mol Cell Biol 2000, 20:402-415.
63. Jiang Y, Xue ZH, Shen WZ, Du KM, Yan H, et al. Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancerbinding protein-α. Leukemia 2005, 19:1239-1247.
64. van de Sluis B, Muller P, Duran K, Chen A, Groot AJ, et al. Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice. Mol Cell Biol 2007, 27:4142-4156.
65. Ao A, Wang H, Kamarajugadda S, Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci U S A 2008, 105:7821-7826.
66. Koh MY, Darnay BG, Powis G. Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1α, leading to its oxygen-independent degradation.Mol Cell Biol 2008, 28:7081-7095.
67. Kato H, Tamamizu-Kato S, Shibasaki F. Histone deacetylase 7 associates with hypoxia-inducible factor 1α and increases transcriptional activity. J Biol Chem 2004, 279:41966-41974.
68. Moon EJ, Jeong CH, Jeong JW, Kim KR, Yu DY, et al. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1α. FASEB J 2004, 18:382-384.
69. Zhang W, Tsuchiya T, Yasukochi Y. Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia. J Hum Genet 1999, 44:293-299.
70. Tendler DS, Bao C, Wang T, Huang EL, Ratovitski EA, et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res 2001, 61:3682-3688.
71. BaeMK, AhnMY, Jeong JW, Bae MH, Lee YM, et al. Jab1 interacts directly with HIF-1α and regulates its stability. J Biol Chem 2002, 277:9-12.
72. Cai Q,MurakamiM, Si H, Robertson ES. A potential α-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1α in normoxia. J Virol 2007, 81:10413-10423.
73. Hogenesch JB, Gu YZ, Moran SM, Shimomura K, Radcliffe LA, et al. The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors. J Neurosci 2000, 20:RC83.
74. Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ. MSF-A interacts with hypoxia-inducible factor-1α and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 2006, 66:856-866.
75. Yoo YG, Kong G, Lee MO. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1. EMBO J 2006, 25:1231-1241.
76. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, et al. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004, 23:1949-1956.
77. Moon HE, Ahn MY, Park JA, Min KJ, Kwon YW, et al. Negative regulation of hypoxia inducible factor-1 alpha by necdin. FEBS Lett 2005, 579:3797-3801.
78. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005, 9:617-628.
79. Fatyol K, Szalay AA. The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1α (HIF-1α) and inhibits HIF-1-mediated transcription. J Biol Chem 2001, 276:28421-28429.
80. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 1998, 392:405-408.
81. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 2000, 14:34-44.
82. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A 1996, 93:12969-12973.
83. Chilov D, Hofer T, Bauer C, Wenger RH, Gassmann M. Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain. FASEB J 2001, 15:2613-2622.
84. Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 2003, 63:7277-7283.
85. Cho S, Choi YJ, Kim JM, Jeong ST, Kim JH, et al. Binding and regulation of HIF-1α by a subunit of the proteasome complex, PSMA7. FEBS Lett 2001, 498:62-66.
86. Land SC, Tee AR. Hypoxia-inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007, 282:20534-20543.
87. Budde A, Schneiderhan-Marra N, Petersen G, Brüne B. Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1). Oncogene 2005, 24:1802-1808.
88. Amir S, Wang R, Simons JW,Mabjeesh NJ. SEPT9 v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation. J Biol Chem2009, 284:11142-11151.
89. Sánchez-Elsner T, Botella LM, Velasco B, Corbí A, Attisano L, et al. Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001, 276: 38527-38535.
90. Koshiji M, To KK, Hammer S, Kumamoto K, Harris AL, et al. HIF-1α induces genetic instability by transcriptionally downregulating MutSα expression. Mol Cell 2005, 17:793-803.
91. Hägele S, Behnam B, Borter E, Wolfe J, Paasch U, et al. TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)-1α. FEBS Lett 2006, 580:3731-3738.
92. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005, 105:659-669.
93. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996, 271:32529-32537.
94. Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004, 279: 24218-24225.
95. Eckhart AD, Yang N, Xin X, Faber JE. Characterization of the α1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci U S A 1997, 94:9487-9492.
96. Cormier-Regard S, Nguyen SV, Claycomb WC. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 1998, 273:17787-17792.
97. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 1998, 12:149-162.
98. Ryan HE, Lo J, Johnson RS. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 1998, 17:3005-3015.
99. Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, et al.Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 2008, 103:432-440.
100. Chun YS, Hyun JY, Kwak YG, Kim IS, Kim CH, et al. Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J 2003, 370:149-157.
101. Weidemann A, Klanke B, Wagner M, Volk T, Willam C, et al. Hypoxia, via stabilization of the hypoxiainducible factor HIF-1α is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J 2008, 409:233-242.
102. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene 2000, 19:6297-6305.
103. Kokkonen N, Ulibarri IF, Kauppila A, Luosujärvi H, Rivinoja A, et al. Hypoxia upregulates carcinoembryonic antigen expression in cancer cells. Int J Cancer 2007, 121:2443-2450.
104. Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of β 2 integrin gene expression. Proc Natl Acad Sci U S A 2004, 101:10440-10445.
105. Mukhopadhyay CK, Mazumder B, Fox PL. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 2000, 275:21048-21054.
106. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361.
107. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, et al. Hypoxic induction of Ctgf is directly mediated by HIF-1. Am J Physiol 2004, 287:F1223-F1232.
108. Kaidi A, Qualtrough D, Williams AC, Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 2006, 66:6683-6691.
109. Fradette C, du Souich P. Hypoxia-inducible factor-1 and activator protein-1 modulate the upregulation of CYP3A6 induced by hypoxia. Br J Pharmacol 2003, 140:1146-1154.
110. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129:111-122.
111. Maxwell PJ, Gallagher R, Seaton A, Wilson C, Scullin P, et al. HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene 2007, 26:7333-7345.
112. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumor suppressor pVHL. Nature 2003, 425:307-311.
113. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003, 198:1391-1402.
114. Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H, et al. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 2002, 277:47014-47021.
115. Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 2008, 118:975-983.
116. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002, 110:993-1002.
117. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001, 412:877-884.
118. Sánchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabéu C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways. J Biol Chem 2002, 277:43799-43808.
119. Coulet F, Nadaud S, Agrapart M, Soubrier F. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 2003, 278:46230-46240.
120. Hu J, Discher DJ, Bishopric NH, Webster KA. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 1998, 245:894-899.
121. Oikawa M, Abe M, Kurosawa H, Hida W, Shirato K, et al. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun 2001, 289:39-43.
122. Oktay Y, Dioum E, Matsuzaki S, Ding K, Yan LJ, et al. Hypoxia-inducible factor 2α regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 2007, 282:11750-11756.
123. Wood SM, Wiesener MS, Yeates KM, Okada N, Pugh CW, et al. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 α-subunit (HIF-1α). Characterization of HIF-1α-dependent and independent hypoxia-inducible gene expression. J Biol Chem 1998, 273:8360-8368.
124. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim Biophys Acta 1999, 1447:208-218.
125. Lu S, Gu X, Hoestje S, Epner DE. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim Biophys Acta 2002, 1574:152-156.
126. Paris S, Denis H, Delaive E, DieuM, Dumont V, et al. Up-regulation of 94-kDa glucose-regulated protein by hypoxia-inducible factor-1 in human endothelial cells in response to hypoxia. FEBS Lett 2005, 579:105-114.
127. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997, 272:5375-5381.
128. Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, et al. Identification of a functional hypoxiaresponsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 2005, 390:189-197.
129. Metzen E, Stiehl DP, Doege K, Marxsen JH, Hellwig-Bürgel T, et al. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem J 2005, 387:711-717.
130. Lee MJ, Kim JY, Suk K, Park JH. Identification of the hypoxia-inducible factor 1α-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway.Mol Cell Biol 2004, 24:3918-3927.
131. Löfstedt T, Jögi A, Sigvardsson M, Gradin K, Poellinger L, et al. Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 2004, 279:39223-39231.
132. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001, 193:1027-1034.
133. Lee SY, Madan A, Furuta GT, Colgan SP, Sibley E. Lactase gene transcription is activated in response to hypoxia in intestinal epithelial cells. Mol Genet Metab 2002, 75:65-69.
134. Fitsialos G, Bourget I, Augier S, Ginouv'es A, Rezzonico R, et al. HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration. J Cell Sci 2008, 121:2992-3001.
135. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, et al. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002, 277:42953-42957.
136. Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, et al. Lysyl oxidase is essential for hypoxiainduced metastasis. Nature 2006, 440:1222-1226.
137. Mojsilovic-Petrovic J, Callaghan D, Cui H, Dean C, Stanimirovic DB, et al. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxiastimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J Neuroinflammation 2007, 4:12.
138. Petrella BL, Lohi J, Brinckerhoff CE. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma. Oncogene 2005, 24:1043-1052.
139. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 2004, 279:37124-37132.
140. UllahMS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism. J Biol Chem 2006, 281:9030-9037.
141. Young HW,Williams OW, Chandra D, Bellinghausen LK, Pérez G, et al. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5′ elements. Am J Respir Cell Mol Biol 2007, 37:273-290.
142. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002, 62:3387-3394.
143. Corn PG, Ricci MS, Scata KA, Arsham AM, Simon MC, et al. Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther 2005, 4:1285-1294.
144. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007, 11:407-420.
145. Piret JP, Minet E, Cosse JP, Ninane N, Debacq C, et al. Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J Biol Chem 2005, 280:9336-9344.
146. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, et al. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J ExpMed 1995, 182:1683-1693.
147. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 2000, 97:9082-9087.
148. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1α. J Exp Med 2004, 199:113-124.
149. Choi JW, Park SC, Kang GH, Liu JO, Youn HD. Nur77 activated by hypoxia-inducible factor-1α overproduces proopiomelanocortin in von Hippel-Lindaumutated renal cell carcinoma. Cancer Res 2004, 64:35-39.
150. Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, et al. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 1999, 13:64-75.
151. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygenregulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci U S A 1994, 91:6496-6500.
152. Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, et al. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 2002, 277:6183-6187.
153. Fukasawa M, Tsuchiya T, Takayama E, Shinomiya N, Uyeda K, et al. Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J Biochem (Tokyo) 2004, 136:273-277.
154. Minchenko O, Opentanova I, Caro J. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 2003, 554:264-270.
155. Kietzmann T, Roth U, Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 1999, 94:4177-4185.
156. Takahashi Y, Takahashi S, Shiga Y, Yoshimi T, Miura T. Hypoxic induction of prolyl 4-hydroxylase α (I) in cultured cells. J Biol Chem2000, 275:14139-14146.
157. TanM, Gu Q, He H, Pamarthy D, Semenza GL, et al. SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1α ubiquitination and degradation. Oncogene 2008, 27:1404-1411.
158. Miki N, Ikuta M, Matsui T. Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor α4 gene by an interaction between hypoxiainducible factor-1 and Sp1. J Biol Chem 2004, 279:15025-15031.
159. Chauvet C, Bois-Joyeux B, Berra E, Pouyssegur J, Danan JL. The gene encoding human retinoic acid-receptor-related orphan receptor α is a target for hypoxia-inducible factor 1. Biochem J 2004, 384:79-85.
160. Amano H, Maruyama K, Naka M, Tanaka T. Target validation in hypoxia-induced vascular remodeling using transcriptome/ metabolome analysis. Pharmacogenomics J 2003, 3:183-188.
161. Law AY, Lai KP, Ip CK, Wong AS, Wagner GF, et al. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Exp Cell Res 2008, 314:1823-1830.
162. Bosch-Marcé M, Okuyama H, Wesley JB, Sarkar K, Kimura H, et al. Effects of aging and hypoxiainducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007, 101:1310-1318.
163. Han ZB, Ren H, Zhao H, Chi Y, Chen K, et al. Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008, 29:1853-1861.
164. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
165. Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, et al. Stromal cell-derived factor-1α and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau lossof-function induces expression of a ligand and its receptor. Cancer Res 2005, 65:6178-6188.
166. Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, et al. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 2004, 24:6076-6083.
167. Yatabe N, Kyo S, Maida Y, Nishi H, Nakamura M, et al. HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene 2004, 23:3708-3715.
168. Rolfs A, Kvietikova I, Gassmann M, Wenger RH. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem 1997, 272:20055-20062.
169. Lok CN, Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 1999, 274:24147-24152.
170. Tacchini L, Fusar Poli D, Bernelli-Zazzera A, Cairo G. Transferrin receptor gene expression and transferrinbound iron uptake are increased during postischemic rat liver reperfusion. Hepatology 2002, 36:103-111.
171. 3. J Clin Invest 2000, 105:577-587.
172. Gort EH, van HaaftenG, Verlaan I, Groot AJ, Plasterk RH, et al. The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α. Oncogene 2008, 27:1501-1510.
173. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, et al. Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 2008, 10:295-305.
174. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.Mol Cell Biol 1996, 16:4604-4613.
175. Gerber H-P, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997, 272:23659-23667.
176. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marcé M, et al. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 2006, 281:15554-15563.
177. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006, 66:2725-2731.
178. Chen KF, Lai YY, Sun HS, Tsai SJ. Transcriptional repression of human cad gene by hypoxia inducible factor-1α. Nucleic Acids Res 2005, 33:5190-5198.
179. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007, 117:1926-1932.
180. Hartsfield CL, Alam J, Choi AM. Differential signaling pathways of HO-1 gene expression in pulmonary and systemic vascular cells. Am J Physiol 1999, 277:L1133-L1141.
181. 2-responsive sequences on the tyrosine hydroxylase gene. J Biol Chem 1995, 270:23774-23770.
182. Xu L, Xie K, Mukaida N, Matsushima K, Fidler IJ. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinomal cells. Cancer Res 1999, 59:5822-5829.
183. Taylor CT, Fueki N, Agah A, Hershberg RM, Colgan SP. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-α. J Biol Chem1999, 274:19447-19454.
184. Yan SF Zou YS, Gao Y, Zhai C, Mackman N, et al. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A 1998, 95:8298-8303.
185. Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000, 6:1355-1361.
186. Yan SF, Lu J, Zou YS, Kisiel W, Mackman N, et al. Protein kinase C-ß and oxygen deprivation: a novel EGR-1-dependent pathway for fibrin deposition in hypoxemic vasculature. J Biol Chem 2000, 275:11921-11928.
187. Ji YS, Xu Q, Schmedtje JF Jr. Hypoxia induces highmobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium. Circ Res 1998, 83:295-304.
188. Yan SF, Zou YS, Mendelsohn M, Gao Y, Naka Y, et al. Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia. J Biol Chem 1997, 272:4287-4294.
189. Matsui H, IharaY, Fujio Y, Kunisada K, Akira S, et al. Induction of interleukin-6 by hypoxia is mediated by NF-κB and NF-IL6 in cardiac myocytes. Cardiovasc Res 1999, 42:104-112.
190. Hehlgans T, Seitz C, Lewis C, Männel DN. Hypoxic upregulation of TNF receptor type 2 expression involves NF-IL-6 and is independent of HIF-1 or HIF-2. J Interferon Cytokine Res 2001, 21:757-762.
191. Glasgow JN, Qiu J, RassinD, Grafe M, Wood T, et al. Transcriptional regulation of the BCL-X gene by NF-κB is an element of hypoxic responses in the rat brain. Neurochem Res 2001, 26:647-659.
192. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT. Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J Immunol 2000, 165:1013-1021.
193. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS.Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997, 272:601-608.
194. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001, 20:4188-4197.
195. Kong T, Scully M, Shelley CS, Colgan SP. Identification of Purα as a new hypoxia response factor responsible for coordinated induction of the β 2 integrin family. J Immunol 2007, 179:1934-1941.
196. Xu Q, Ji YS, Schmedtje JF Jr. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. J Biol Chem 2000, 275:24583-24589.
197. Discher DJ, Bishopric NH, Wu X, Peterson CA, Webster KA. Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J Biol Chem 1998, 273:26087-26093.
198. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, et al. Genome-wide association of hypoxiainducible factor HIF-1α and HIF-2α DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 2009, 284:16767-16775.
199. Xia X, Lemieux ME, LiW, Carroll JS, Brown M, et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci U S A 2009, 106:4260-4265.
200. Rana TM. Illuminating the silence: Understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 2007, 8:23-36.
201. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, et al. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
202. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
203. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, et al. A microRNA signature of hypoxia. Mol Cell Biol 2007, 27:1859-1867.
204. Wellmann S, Bettkober M, Zelmer A, Seeger K, Faigle M, et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun 2008, 372:892-897.
205. Pollard PJ, Loenarz C, Mole DR, McDonough MA, Gleadle JM, et al. Regulation of Jumonji-domain containing histone demethylases by hypoxia inducible factor (HIF) 1α. Biochem J 2008, 416:387-394.
206. Ozer A, Bruick RK. Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol 2007, 3:144-153.
207. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2α promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007, 11:335-347.
208. Yoon D, Pastore YD, Divoky V, Liu E,Mlodnicka AE, et al. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 2006, 281:25703-25711.
209. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403-407.
210. Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 2000, 97:8386-8391.
211. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998, 12:3320-3324.
212. Compernolle V, Brusselmans K, Acker T, Hoet P, TjwaM, et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002, 8:702-710.
213. Scortegagna M, Ding K, Oktay Y, et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1 {-/-}mice. Nat Genet 2003, 35:331-340.
214. Seagroves TN, Hadsell D, McManaman J, Palmer C, Liao D, et al. HIF-1α is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 2003, 130:1713-1724.
215. Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, et al. Cardiac myocyte-specific HIF-1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 2004, 18:1138-1140.
216. Schipani E. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev 2001, 15:2865-2876.
217. Provot S, Zinyk D, Gunes Y, Kathri R, Le Q, et al. HIF-1α regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 2007, 177:451-464.
218. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004, 114:1098-1106.
219. Boutin AT,Weidemann A, Fu Z, Mesropian L, Gradin K, et al. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008, 133:223-234.
220. Peyssonnaux C, Boutin AT, Zinkernagel AS, Datta V, Nizet V, et al. Critical role of HIF-1α in keratinocyte defense against bacterial infection. J Invest Dermatol 2008, 128:1964-1968.
221. Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657.
222. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, et al. HIF-1α expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005, 115:1806-1815.
223. Kojima H, Gu H, Nomura S, Caldwell CC, Kobata T, et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice. Proc Natl Acad Sci U S A 2002, 99:2170-2174.
224. Neumann AK, Yang J, Biju MP, Joseph SK, Johnson RS, et al. Hypoxia inducible factor 1α regulates T cell receptor signal transduction. Proc Natl Acad Sci U S A 2005, 102:17071-17076.
225. Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, et al. Targeted deletion of HIF-1α gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE 2007, 2:e853.
226. Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, et al. Defective brain development in mice lacking the Hif-1α gene in neural cells. Mol Cell Biol 2003, 23:6739-6749.
227. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, et al. Neuron-specific inactivation of the hypoxia inducible factor 1α increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 2007, 27:6320-6332.
228. Wang Y, Wan C, Deng L, Liu X, Cao X, et al. The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007, 117:1616-1626.
229. Mason SD, Rundqvist H, Papandreou I, Duh R, McNulty WJ, et al. HIF-1α in endurance training: suppression of oxidative metabolism. Am J Physiol 2007, 293:R2059-R2069.
230. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxiainducible factor 1α. J Clin Invest 1999, 103: 691-696.
231. Shimoda LA, Manalo DJ, Sham JS, Semenza GL, Sylvester JT. Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol 2001, 281:L202-L208.
232. Shimoda LA, Fallon M, Pisarcik S, Wang J, Semenza GL. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol 2006, 291:L941-L949.
233. 2+ in pulmonary arterial smooth muscle cells. Circ Res 2006, 98:1528-1537.
234. + channel expression in pulmonary arterial myocytes. Am J Physiol 2008, 294:309-310.
235. Kline DD, Peng YJ, Manalo DJ, Semenza GL, Prabhakar NR. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proc Natl Acad Sci U S A 2002, 99:821-826.
236. Li J, Bosch-Marcé M, Nanayakkara A, Savransky V, Fried SK, et al. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor 1α. Physiol Genomics 2006, 25:450-457.
237. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marcé M, et al. Heterozygous HIF-1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 2006, 577:705-716.
238. Cai Z, Zhong H, Bosch-Marcé M, Fox-Talbot K, Wang L, et al. Complete loss of ischemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α. Cardiovasc Res 2008, 77:463-470.
239. Prabhakar NR. Oxygen sensing by the carotid body chemoreceptors. J Appl Physiol 2000, 88: 2287-2295.
240. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003, 108:79-85.
241. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, et al. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007, 117:1068-1077.
242. Patel TH, Kimura H, Weiss CR, Semenza GL, Hofmann LV. Constitutively active HIF-1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc Res 2005, 68:144-154.
243. Pajusola K, Künnapuu J, Vuorikoski S, Soronen J, André H, et al. Stabilized HIF-1α is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J 2005, 19:1365-1367.
244. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006, 3:177-185.
245. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC.HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006, 3:187-197.
246. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, et al. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007, 27:6229-6242.
247. Zhang H, Bosch-Marcé M, Shimoda LA, Tan YS, Baek JH, et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008, 283:10892-10903.
248. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009, 29:2570-2581.
249. Sandoval H, Thiagarajan P, Dasgupta SK, Schumacher A, Prchal JT, et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 2008, 454:232-235.
250. Tuder RM, McGrath S, Voelkel NF, Geraci MW. Oxygen-dependent regulation of pulmonary circulation. Methods Enzymol 2004, 381:87-106.
251. v channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 2006, 113:2630-2641.
252. 2+/calmodulin kinase-dependent activation of hypoxia-inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 2005, 280:4321-4328.
253. 2+ signaling, prolyl hydroxylases, andmTOR. J Cell Physiol 2008, 217:674-685.
254. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 2002, 32:614-621.
255. Percy MJ, Zhao Q, Flores A, Harrison C, Lappin TR, et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A 2006, 103:654-659.
256. PercyMJ, Furlow PW, Beer PA, Lappin TR, McMullin MF, et al. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. Blood 2007, 110:2193-2196.
257. Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, et al. PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl JMed 2008, 359:2685-2692.
258. Percy MJ, Furlow PW, Lucas GS, Li X, Lappin TR, et al. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med 2008, 358:162-168.
259. Perrotta S, Della Ragione F. The HIF2A gene in familial erythrocytosis. N Engl JMed 2008, 358:1966.
260. Bushuev VI, Miasnikova GY, Sergueeva AI, Polyakova LA, Okhotin D, et al. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica 2006, 91:744-749.
261. Smith TG, Brooks JT, Balanos GM, Lappin TR, Layton DM, et al. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med 2006, 3:e290.
262. Hansen J. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989, 117:290-295.
263. Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ, et al. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1, and HIF-1α in renal cell carcinoma. Oncogene 2001, 20:5067-5074.
264. Resar JR, Roguin A, Voner J, Nasir K, Hennebry TA, et al. Hypoxia-inducible factor 1α polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 2005, 128:787-791.
265. Hlatky MA, Quertermous T, Boothroyd DB, Priest JR, Glassford AJ, et al. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J 2007, 154:1035-1042.
266. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999, 59:5830-5835.
267. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000, 157:411-421.
268. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732.
269. Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002, 1:237-246.
270. Semenza GL. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today 2007, 12:853-859.
271. Melillo G. Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev 2007, 26:341-352.
272. Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin SE, et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1α stabilization during ischemia. Circulation 2007, 116:2818-2829.
273. Liu L, Marti GP, Wei X, Zhang X, Zhang H, et al. Age-dependent impairment of HIF-1α expression in diabetic mice: Correction with electroporationfacilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol 2008, 217:319-327.
274. Botusan IR, Sunkari VG, Savu O, Catrina AI, Grünler J, et al. Stabilization of HIF-1α is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A 2008, 105:19426-19431.
275. Ceradini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 2008, 283:10930-10938.
276. Harris AL. Hypoxia-a key regulatory factor in tumor growth. Nat Rev Cancer 2002, 2:38-47.
277. Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, et al. Use of a constitutively active hypoxiainducible factor-1α transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience. Circulation 2007, 115:1234-1243.
278. Lim JH, Park JW, Kim SJ, Kim MS, Park SK, et al. ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1α (HIF-1α) binding and mediates HIF-1α expression by bafilomycin A1. Mol Pharmacol 2007, 71:942-948.